Atlas Trials

A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer

Clinical trial NCT05939661 · RECRUITING

Trial details

NCT number
NCT05939661
Sponsor
Osaka University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2023-05-25
Primary completion
2026-03-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.